nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—CYP19A1—Betamethasone—ankylosing spondylitis	0.579	0.632	CbGbCtD
Carbimazole—CYP19A1—Dexamethasone—ankylosing spondylitis	0.337	0.368	CbGbCtD
Carbimazole—Myopathy—Prednisolone—ankylosing spondylitis	0.00203	0.024	CcSEcCtD
Carbimazole—Myopathy—Triamcinolone—ankylosing spondylitis	0.00187	0.0221	CcSEcCtD
Carbimazole—Myopathy—Methylprednisolone—ankylosing spondylitis	0.00187	0.022	CcSEcCtD
Carbimazole—Throat sore—Triamcinolone—ankylosing spondylitis	0.00182	0.0215	CcSEcCtD
Carbimazole—Oropharyngeal discomfort—Triamcinolone—ankylosing spondylitis	0.0018	0.0213	CcSEcCtD
Carbimazole—Myopathy—Dexamethasone—ankylosing spondylitis	0.0017	0.02	CcSEcCtD
Carbimazole—Myopathy—Betamethasone—ankylosing spondylitis	0.0017	0.02	CcSEcCtD
Carbimazole—Myopathy—Prednisone—ankylosing spondylitis	0.00148	0.0175	CcSEcCtD
Carbimazole—Oropharyngeal pain—Triamcinolone—ankylosing spondylitis	0.00144	0.017	CcSEcCtD
Carbimazole—Contusion—Betamethasone—ankylosing spondylitis	0.00136	0.0161	CcSEcCtD
Carbimazole—Contusion—Dexamethasone—ankylosing spondylitis	0.00136	0.0161	CcSEcCtD
Carbimazole—Bone marrow depression—Methotrexate—ankylosing spondylitis	0.00128	0.0152	CcSEcCtD
Carbimazole—Liver disorder—Methotrexate—ankylosing spondylitis	0.00127	0.015	CcSEcCtD
Carbimazole—Contusion—Prednisone—ankylosing spondylitis	0.00119	0.014	CcSEcCtD
Carbimazole—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.000813	0.0096	CcSEcCtD
Carbimazole—Mouth ulceration—Methotrexate—ankylosing spondylitis	0.000783	0.00925	CcSEcCtD
Carbimazole—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00072	0.0085	CcSEcCtD
Carbimazole—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000716	0.00846	CcSEcCtD
Carbimazole—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000662	0.00782	CcSEcCtD
Carbimazole—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000661	0.0078	CcSEcCtD
Carbimazole—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000659	0.00778	CcSEcCtD
Carbimazole—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000657	0.00776	CcSEcCtD
Carbimazole—Neutropenia—Prednisone—ankylosing spondylitis	0.000608	0.00718	CcSEcCtD
Carbimazole—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000601	0.00709	CcSEcCtD
Carbimazole—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000601	0.00709	CcSEcCtD
Carbimazole—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000598	0.00706	CcSEcCtD
Carbimazole—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000598	0.00706	CcSEcCtD
Carbimazole—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000596	0.00704	CcSEcCtD
Carbimazole—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000581	0.00685	CcSEcCtD
Carbimazole—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000579	0.00683	CcSEcCtD
Carbimazole—Angioedema—Prednisolone—ankylosing spondylitis	0.00057	0.00673	CcSEcCtD
Carbimazole—Malaise—Prednisolone—ankylosing spondylitis	0.000562	0.00664	CcSEcCtD
Carbimazole—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000542	0.0064	CcSEcCtD
Carbimazole—Angiopathy—Betamethasone—ankylosing spondylitis	0.000542	0.0064	CcSEcCtD
Carbimazole—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000538	0.00635	CcSEcCtD
Carbimazole—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000532	0.00628	CcSEcCtD
Carbimazole—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000531	0.00627	CcSEcCtD
Carbimazole—Alopecia—Dexamethasone—ankylosing spondylitis	0.000528	0.00624	CcSEcCtD
Carbimazole—Alopecia—Betamethasone—ankylosing spondylitis	0.000528	0.00624	CcSEcCtD
Carbimazole—Discomfort—Prednisolone—ankylosing spondylitis	0.000524	0.00619	CcSEcCtD
Carbimazole—Angioedema—Triamcinolone—ankylosing spondylitis	0.000524	0.00619	CcSEcCtD
Carbimazole—Haemoglobin—Prednisone—ankylosing spondylitis	0.000523	0.00618	CcSEcCtD
Carbimazole—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000523	0.00617	CcSEcCtD
Carbimazole—Haemorrhage—Prednisone—ankylosing spondylitis	0.000521	0.00615	CcSEcCtD
Carbimazole—Malaise—Triamcinolone—ankylosing spondylitis	0.000517	0.00611	CcSEcCtD
Carbimazole—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000516	0.00609	CcSEcCtD
Carbimazole—Malaise—Methylprednisolone—ankylosing spondylitis	0.000516	0.00609	CcSEcCtD
Carbimazole—Neutropenia—Methotrexate—ankylosing spondylitis	0.000508	0.006	CcSEcCtD
Carbimazole—Myalgia—Triamcinolone—ankylosing spondylitis	0.000488	0.00576	CcSEcCtD
Carbimazole—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000487	0.00575	CcSEcCtD
Carbimazole—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000487	0.00575	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000484	0.00571	CcSEcCtD
Carbimazole—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000483	0.0057	CcSEcCtD
Carbimazole—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000483	0.0057	CcSEcCtD
Carbimazole—Discomfort—Triamcinolone—ankylosing spondylitis	0.000482	0.0057	CcSEcCtD
Carbimazole—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000481	0.00568	CcSEcCtD
Carbimazole—Angioedema—Betamethasone—ankylosing spondylitis	0.000475	0.00561	CcSEcCtD
Carbimazole—Angioedema—Dexamethasone—ankylosing spondylitis	0.000475	0.00561	CcSEcCtD
Carbimazole—Stomatitis—Methotrexate—ankylosing spondylitis	0.000472	0.00558	CcSEcCtD
Carbimazole—Angiopathy—Prednisone—ankylosing spondylitis	0.000472	0.00558	CcSEcCtD
Carbimazole—Malaise—Dexamethasone—ankylosing spondylitis	0.000469	0.00554	CcSEcCtD
Carbimazole—Malaise—Betamethasone—ankylosing spondylitis	0.000469	0.00554	CcSEcCtD
Carbimazole—Infection—Triamcinolone—ankylosing spondylitis	0.000465	0.00549	CcSEcCtD
Carbimazole—Infection—Methylprednisolone—ankylosing spondylitis	0.000464	0.00548	CcSEcCtD
Carbimazole—Alopecia—Prednisone—ankylosing spondylitis	0.00046	0.00543	CcSEcCtD
Carbimazole—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000458	0.00541	CcSEcCtD
Carbimazole—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000454	0.00536	CcSEcCtD
Carbimazole—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000452	0.00534	CcSEcCtD
Carbimazole—Myalgia—Dexamethasone—ankylosing spondylitis	0.000443	0.00523	CcSEcCtD
Carbimazole—Myalgia—Betamethasone—ankylosing spondylitis	0.000443	0.00523	CcSEcCtD
Carbimazole—Discomfort—Betamethasone—ankylosing spondylitis	0.000438	0.00517	CcSEcCtD
Carbimazole—Discomfort—Dexamethasone—ankylosing spondylitis	0.000438	0.00517	CcSEcCtD
Carbimazole—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000437	0.00516	CcSEcCtD
Carbimazole—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000435	0.00514	CcSEcCtD
Carbimazole—Hepatitis—Methotrexate—ankylosing spondylitis	0.000435	0.00514	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000426	0.00503	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000425	0.00502	CcSEcCtD
Carbimazole—Infection—Betamethasone—ankylosing spondylitis	0.000422	0.00498	CcSEcCtD
Carbimazole—Infection—Dexamethasone—ankylosing spondylitis	0.000422	0.00498	CcSEcCtD
Carbimazole—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00042	0.00496	CcSEcCtD
Carbimazole—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000419	0.00495	CcSEcCtD
Carbimazole—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000416	0.00492	CcSEcCtD
Carbimazole—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000416	0.00492	CcSEcCtD
Carbimazole—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000416	0.00491	CcSEcCtD
Carbimazole—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000416	0.00491	CcSEcCtD
Carbimazole—Angioedema—Prednisone—ankylosing spondylitis	0.000414	0.00489	CcSEcCtD
Carbimazole—Malaise—Prednisone—ankylosing spondylitis	0.000409	0.00482	CcSEcCtD
Carbimazole—Urticaria—Prednisolone—ankylosing spondylitis	0.000404	0.00477	CcSEcCtD
Carbimazole—Angiopathy—Methotrexate—ankylosing spondylitis	0.000395	0.00466	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000387	0.00457	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000387	0.00457	CcSEcCtD
Carbimazole—Arthralgia—Prednisone—ankylosing spondylitis	0.000386	0.00455	CcSEcCtD
Carbimazole—Myalgia—Prednisone—ankylosing spondylitis	0.000386	0.00455	CcSEcCtD
Carbimazole—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000386	0.00455	CcSEcCtD
Carbimazole—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000385	0.00454	CcSEcCtD
Carbimazole—Alopecia—Methotrexate—ankylosing spondylitis	0.000384	0.00454	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000383	0.00452	CcSEcCtD
Carbimazole—Discomfort—Prednisone—ankylosing spondylitis	0.000381	0.0045	CcSEcCtD
Carbimazole—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000375	0.00443	CcSEcCtD
Carbimazole—Urticaria—Triamcinolone—ankylosing spondylitis	0.000372	0.00439	CcSEcCtD
Carbimazole—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000371	0.00438	CcSEcCtD
Carbimazole—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00037	0.00437	CcSEcCtD
Carbimazole—Infection—Prednisone—ankylosing spondylitis	0.000367	0.00434	CcSEcCtD
Carbimazole—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000363	0.00428	CcSEcCtD
Carbimazole—Skin disorder—Prednisone—ankylosing spondylitis	0.000359	0.00424	CcSEcCtD
Carbimazole—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000351	0.00415	CcSEcCtD
Carbimazole—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00035	0.00413	CcSEcCtD
Carbimazole—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00035	0.00413	CcSEcCtD
Carbimazole—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000345	0.00407	CcSEcCtD
Carbimazole—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000344	0.00406	CcSEcCtD
Carbimazole—Malaise—Methotrexate—ankylosing spondylitis	0.000341	0.00403	CcSEcCtD
Carbimazole—Leukopenia—Methotrexate—ankylosing spondylitis	0.000339	0.004	CcSEcCtD
Carbimazole—Urticaria—Betamethasone—ankylosing spondylitis	0.000337	0.00398	CcSEcCtD
Carbimazole—Urticaria—Dexamethasone—ankylosing spondylitis	0.000337	0.00398	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000337	0.00398	CcSEcCtD
Carbimazole—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000336	0.00396	CcSEcCtD
Carbimazole—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000336	0.00396	CcSEcCtD
Carbimazole—Pruritus—Triamcinolone—ankylosing spondylitis	0.000331	0.00391	CcSEcCtD
Carbimazole—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00033	0.0039	CcSEcCtD
Carbimazole—Myalgia—Methotrexate—ankylosing spondylitis	0.000322	0.00381	CcSEcCtD
Carbimazole—Arthralgia—Methotrexate—ankylosing spondylitis	0.000322	0.00381	CcSEcCtD
Carbimazole—Rash—Prednisolone—ankylosing spondylitis	0.000321	0.00379	CcSEcCtD
Carbimazole—Dermatitis—Prednisolone—ankylosing spondylitis	0.000321	0.00379	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00032	0.00378	CcSEcCtD
Carbimazole—Headache—Prednisolone—ankylosing spondylitis	0.000319	0.00376	CcSEcCtD
Carbimazole—Discomfort—Methotrexate—ankylosing spondylitis	0.000319	0.00376	CcSEcCtD
Carbimazole—Infection—Methotrexate—ankylosing spondylitis	0.000307	0.00363	CcSEcCtD
Carbimazole—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000305	0.0036	CcSEcCtD
Carbimazole—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000303	0.00358	CcSEcCtD
Carbimazole—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000303	0.00357	CcSEcCtD
Carbimazole—Nausea—Prednisolone—ankylosing spondylitis	0.000302	0.00357	CcSEcCtD
Carbimazole—Pruritus—Betamethasone—ankylosing spondylitis	0.0003	0.00355	CcSEcCtD
Carbimazole—Pruritus—Dexamethasone—ankylosing spondylitis	0.0003	0.00355	CcSEcCtD
Carbimazole—Skin disorder—Methotrexate—ankylosing spondylitis	0.0003	0.00354	CcSEcCtD
Carbimazole—Rash—Triamcinolone—ankylosing spondylitis	0.000295	0.00348	CcSEcCtD
Carbimazole—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000295	0.00348	CcSEcCtD
Carbimazole—Rash—Methylprednisolone—ankylosing spondylitis	0.000294	0.00348	CcSEcCtD
Carbimazole—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000294	0.00347	CcSEcCtD
Carbimazole—Urticaria—Prednisone—ankylosing spondylitis	0.000294	0.00347	CcSEcCtD
Carbimazole—Headache—Triamcinolone—ankylosing spondylitis	0.000293	0.00346	CcSEcCtD
Carbimazole—Headache—Methylprednisolone—ankylosing spondylitis	0.000293	0.00345	CcSEcCtD
Carbimazole—Body temperature increased—Prednisone—ankylosing spondylitis	0.000292	0.00345	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000282	0.00332	CcSEcCtD
Carbimazole—Nausea—Triamcinolone—ankylosing spondylitis	0.000278	0.00328	CcSEcCtD
Carbimazole—Nausea—Methylprednisolone—ankylosing spondylitis	0.000277	0.00328	CcSEcCtD
Carbimazole—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000272	0.00322	CcSEcCtD
Carbimazole—Rash—Dexamethasone—ankylosing spondylitis	0.000268	0.00316	CcSEcCtD
Carbimazole—Rash—Betamethasone—ankylosing spondylitis	0.000268	0.00316	CcSEcCtD
Carbimazole—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000267	0.00316	CcSEcCtD
Carbimazole—Dermatitis—Betamethasone—ankylosing spondylitis	0.000267	0.00316	CcSEcCtD
Carbimazole—Headache—Betamethasone—ankylosing spondylitis	0.000266	0.00314	CcSEcCtD
Carbimazole—Headache—Dexamethasone—ankylosing spondylitis	0.000266	0.00314	CcSEcCtD
Carbimazole—Pruritus—Prednisone—ankylosing spondylitis	0.000262	0.00309	CcSEcCtD
Carbimazole—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000255	0.00301	CcSEcCtD
Carbimazole—Nausea—Dexamethasone—ankylosing spondylitis	0.000252	0.00298	CcSEcCtD
Carbimazole—Nausea—Betamethasone—ankylosing spondylitis	0.000252	0.00298	CcSEcCtD
Carbimazole—Urticaria—Methotrexate—ankylosing spondylitis	0.000246	0.0029	CcSEcCtD
Carbimazole—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000244	0.00288	CcSEcCtD
Carbimazole—Rash—Prednisone—ankylosing spondylitis	0.000233	0.00275	CcSEcCtD
Carbimazole—Dermatitis—Prednisone—ankylosing spondylitis	0.000233	0.00275	CcSEcCtD
Carbimazole—Headache—Prednisone—ankylosing spondylitis	0.000232	0.00274	CcSEcCtD
Carbimazole—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000228	0.00269	CcSEcCtD
Carbimazole—Nausea—Prednisone—ankylosing spondylitis	0.00022	0.00259	CcSEcCtD
Carbimazole—Pruritus—Methotrexate—ankylosing spondylitis	0.000219	0.00258	CcSEcCtD
Carbimazole—Rash—Methotrexate—ankylosing spondylitis	0.000195	0.0023	CcSEcCtD
Carbimazole—Dermatitis—Methotrexate—ankylosing spondylitis	0.000195	0.0023	CcSEcCtD
Carbimazole—Headache—Methotrexate—ankylosing spondylitis	0.000194	0.00229	CcSEcCtD
Carbimazole—Nausea—Methotrexate—ankylosing spondylitis	0.000184	0.00217	CcSEcCtD
